HSBC Holdings
DGX icon

HSBC Holdings’s Quest Diagnostics DGX Stock Holding History

HSBC Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-55,000
Closed -$4.58M – 2737
2018
Q4 		$4.58M Hold
55,000
– – 0.01% 1138
2018
Q3 		$5.93M Hold
55,000
– – 0.01% 1054
2018
Q2 		$6.05M Buy
+55,000
New +$5.73M 0.01% 1029

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HSBC Holdings's DGX Position: Q2 2026 in Review

HSBC Holdings increased its Quest Diagnostics (DGX) stake by 15% in Q2 2026, buying an estimated $5.86M and bringing the position to 224,986 shares worth $47.8M. The position accounts for 0.02% of the portfolio, ranked #555.

HSBC Holdings first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $96M in Q4 2022. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • HSBC Holdings held 224,986 shares of Quest Diagnostics worth $47.8M as of Q2 2026.
  • HSBC Holdings bought 29,842 Quest Diagnostics shares in Q2 2026, an estimated $5.86M.
  • Quest Diagnostics made up 0.02% of HSBC Holdings's portfolio in Q2 2026, its #555 holding.
  • HSBC Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • HSBC Holdings's Quest Diagnostics position peaked at $96M in Q4 2022.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.